CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues

CPT-11 is a prodrug activated by carboxylesterases to the active metabolite SN-38 which is a potent inhibitor of topoisomerase I. CPT-11 is of clinical interest in the treatment of colorectal cancer. We evaluated the activities of CPT-11 converting carboxylesterase (CPT-CE) and topoisomerase I (topo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guichard, S, Terret, C, Hennebelle, I, Lochon, I, Chevreau, P, Frétigny, E, Selves, J, Chatelut, E, Bugat, R, Canal, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362335/
https://www.ncbi.nlm.nih.gov/pubmed/10408839
http://dx.doi.org/10.1038/sj.bjc.6690364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362335/
https://www.ncbi.nlm.nih.gov/pubmed/10408839
http://dx.doi.org/10.1038/sj.bjc.6690364

Ejemplares similares